In short the two studies are very different in design. Firstly study Geno 003 Phase I was in HSV-2 positive people whereas ours was in HSV-2 negative people so we couldn’t compare viral shedding numbers. Our next study will be in these positive people.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.99 |
Change
-0.150(2.44%) |
Mkt cap ! $92.83M | |||
| Open | High | Low | Value | Volume |
| $6.10 | $6.10 | $5.78 | $105.6K | 17.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $6.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.30 | 100 | 1 |
View Market Depth
| Last trade - 15.55pm 01/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |